Cytex Accepted in NIH Commercialization Acceleration Program

Cytex is delighted to be awarded entry to the highly successful Commercialization Acceleration Program offered as a competitive award to recipients of NIH Phase II SBIR or STTR awards.  The program provides training and support for Cytex staff in commercialization activities such as regulatory planning, investment negotiations, and product marketing.

Continue reading


Cytex Technology Featured in US News and World Report

Cytex’s technology, as published in the latest Proceedings of the National Academy of Sciences, is making a splash worldwide.  Cytex’s scientists and cartilage resurfacing technology was featured in U.S. News and World Report Health News, The Huffington Post, Health, Yahoo News, and dozens of other news outlets in response to the recently published study in […]

Continue reading


Cytex Hip Resurfacing Technology Featured in PNAS

Cytex’s VP of Research and Development, Dr. Brad Estes and Dr. Farsh Guilak, Professor of Orthopaedic Surgery at Washington University and Cytex’s President, co-led a team of researchers in a study published July 18, 2016 in the prestigious journal PNAS.  Results from this study highlighted Cytex’s tissue engineered implants’ cartilage-like properties, ability to maintain complex […]

Continue reading


Dr. Frank Moutos, Cytex VP of Technology Development, Gives Podium Presentation at the Orthopaedic Research Society

The ORS hosts the premier orthopaedic research conference for basic science and clinical researchers in the United States.  Dr. Moutos presented findings from cutting-edge research in a talk entitled “Anatomically Shaped Tissue-Engineered Cartilage with Tunable and Inducible Anti-Cytokine Delivery for Biological Joint Resurfacing.”

Continue reading